RxDoctor Payments Data

Jung Park

Optometrist · Middletown, DENPI 1487843587

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $382 and has fallen 54.2% since, to $175 in 2025.

$1,669in general payments, 2019–2025

Across 39 payments — averaging $42.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$397
  • Coopervision Inc.$341
  • Sun Pharmaceutical Industries Inc.$221
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$157
  • Eyevance Pharmaceuticals LLC$135
  • Bausch & Lomb Americas Inc.$96
  • plus $321 from 10 others

What the payments were for

  • Food & beverage$1,65199%
  • Gifts$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,669 in reported general payments places this provider in the 75th percentile of 146 optometrist providers in Delaware.

See all optometrist providers in Delaware

Medicare billing

Part B allowed, 2024
$14,323
Medicare patients
110
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErythromycinErythromycin Base13$138
Latanoprost13$71

Paid to pharmacies, not to this prescriber.

Other optometrist in Middletown

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →